Merck & Co. Under Pressure Following Patent Ruling By: Benzinga via Benzinga December 09, 2014 at 09:30 AM EST Merck & Co., Inc. (NYSE: MRK) shares traded lower in the pre-market amid news that its deal to acquire Cubist Pharmaceuticals Inc ... Read More >> Related Stocks: Macy's Merck & Co